Business Description
Vectorite Biomedical Inc
ISIN : TW0004170006
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.95 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 19.09 | |||||
Beneish M-Score | -2.92 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 26.5 | |||||
3-Year EBITDA Growth Rate | 56.2 | |||||
3-Year EPS without NRI Growth Rate | 53 | |||||
3-Year FCF Growth Rate | 63.2 | |||||
3-Year Book Growth Rate | 13.2 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.13 | |||||
9-Day RSI | 42.6 | |||||
14-Day RSI | 44.59 | |||||
6-1 Month Momentum % | -6.35 | |||||
12-1 Month Momentum % | -33.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 16.86 | |||||
Quick Ratio | 15.73 | |||||
Cash Ratio | 15.22 | |||||
Days Inventory | 106.24 | |||||
Days Sales Outstanding | 29.9 | |||||
Days Payable | 14.54 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.3 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 25.07 | |||||
Operating Margin % | -46.65 | |||||
Net Margin % | -37.74 | |||||
FCF Margin % | -24.75 | |||||
ROE % | -4.7 | |||||
ROA % | -4.48 | |||||
ROIC % | -10.34 | |||||
ROC (Joel Greenblatt) % | -13.41 | |||||
ROCE % | -5.69 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 12.28 | |||||
PB Ratio | 1.58 | |||||
Price-to-Tangible-Book | 1.61 | |||||
EV-to-EBIT | -17.7 | |||||
EV-to-EBITDA | -27.58 | |||||
EV-to-Revenue | 8.25 | |||||
EV-to-FCF | -34.85 | |||||
Price-to-Net-Current-Asset-Value | 3.3 | |||||
Price-to-Net-Cash | 3.7 | |||||
Earnings Yield (Greenblatt) % | -5.66 | |||||
FCF Yield % | -2.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Vectorite Biomedical Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 53.473 | ||
EPS (TTM) (NT$) | -0.46 | ||
Beta | 0.33 | ||
Volatility % | 98.2 | ||
14-Day RSI | 44.59 | ||
14-Day ATR (NT$) | 0.473936 | ||
20-Day SMA (NT$) | 14.8475 | ||
12-1 Month Momentum % | -33.43 | ||
52-Week Range (NT$) | 11.55 - 27.2 | ||
Shares Outstanding (Mil) | 43.77 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vectorite Biomedical Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vectorite Biomedical Inc Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Vectorite Biomedical Inc Frequently Asked Questions
What is Vectorite Biomedical Inc(ROCO:4170)'s stock price today?
When is next earnings date of Vectorite Biomedical Inc(ROCO:4170)?
Does Vectorite Biomedical Inc(ROCO:4170) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |